Effectiveness of acupuncture and moxibustion therapy on glycolipid metabolism in patients with obese-type polycystic ovarian syndrome: A systematic review and network meta-analysis
Abstract
Background: The efficacy of acupuncture and moxibustion-related therapy (AMRT) on the glycolipid metabolism in patients with polycystic ovarian syndrome (PCOS), especially those with an obese phenotype, is still uncertain. This paper aims to analyze the impact of AMRT on glycolipid metabolism in managing obese-type PCOS.
Methods: This systematic review and meta-analysis synthesized evidence from randomized controlled trials on AMRT, compared to conventional western medicine or blank control for obese PCOS focusing on their glycolipid metabolism, searched across 7 databases. Direct and Indirect Meta-analysis was conducted using Review Manager 5.4 and R program, presenting continuous data as mean differences (MD) with 95% confidence intervals (CIs). The Cochrane risk-of-bias tool for trials 2 (ROB2) was used for methodological quality assessment, and the Grading of Recommendation Assessment, Development, and Evaluation (GRADE) approach evaluated the certainty of evidence.
Results: Thirty randomized controlled trials were included. Compared to control treatments, AMRT significantly improved fasting plasma glucose (FPG) (MD = -0.19, 95% CI = -0.28 to -0.09, moderate certainty), Weight (W) (MD = -2.34, 95% CI = -4.51 to -0.17, moderate certainty) and triglycerides (TG) (MD = -0.35, 95% CI = -0.40 to -0.29, moderate certainty), and showed similar benefits for low-density lipoprotein (MD = -0.20, 95% CI = -0.40 to -0.01, moderate certainty) and total cholesterol (MD = -0.36, 95% CI…
How strong is the evidence?
Evidence Hub reads this as a meta-analysis, done in people. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid.
Read the paper
Related studies
- Increased expression of circulating miRNA-93 in women with polycystic ovary syndrome may represent a novel, non-invasive biomarker for diagnosis
- Identification of key genes associated with polycystic ovary syndrome (PCOS) and ovarian cancer using an integrated bioinformatics analysis
- Identification of key pathways and genes in polycystic ovary syndrome via integrated bioinformatics analysis and prediction of small therapeutic molecules
- Regulation of Androgen Receptor Expression Alters AMPK Phosphorylation in the Endometrium: In Vivo and In Vitro Studies in Women with Polycystic Ovary Syndrome
- Effect of oral administration of low-dose follicle stimulating hormone on hyperandrogenized mice as a model of polycystic ovary syndrome
- Systems pharmacology to investigate the interaction of berberine and other drugs in treating polycystic ovary syndrome
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.